Cardiac Safety Services Market Report 2021-2031

Global Cardiac services is likely to grow by the factors such as growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increased outsourcing of R&D activities, and increasing number of clinical trials, the introduction of new technology and methods and growth in the biosimilars and biologics market are expected to provide a wide range of growth.

SKU: PHA0934 Category: Diagnostics Tag: PHA0934 Code: PHA0934Pages: 145

Download Sample Form

"*" indicates required fields

Name*

Company*

Designation*

Job Title

Industry

Email*

Phone*

Address*

This field is hidden when viewing the form

Report Title

This field is hidden when viewing the form

Sample url

← Back to category Diagnostics

Description

Cardiac Safety Services Market-our new study reveals current trends, technological advancements, and predicted revenues
Where the Cardiac Safety Services market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 140+ page report provides 150+ tables, 150+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Cardiac Safety Services market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

, In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors

, You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players

, Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.

Report Scope

Global Cardiac Safety Services market 2021-2031 is segmented on the basis of Type, End Users and Geography.

• Revenue and growth forecasts from 2021 to 2031 for the Global Cardiac Safety Services Market by Type:

, Integrated Services

, Standalone Services

• Revenue and growth forecasts from 2021 to 2031 for the Global Cardiac Safety Services Market by End User:

, Pharmaceutical & Biopharmaceutical Companies

, Contract Research Organizations

• Revenue and growth forecasts from 2021 to 2031 for the Global Cardiac Safety Services Market by Region:

, North America: US, Canada

, Europe: Germany, UK, Italy, France, Spain, Rest of Europe

, Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific

, Latin America: Brazil, Mexico, and Rest of Latin America

, Middle East & Africa: GCC, South Africa, Rest of MEA

• Our study discusses the selected leading companies that are the major players in the Cardiac Safety Services industry:

, Biotrial (France)

, Banook Group (France & Canada)

, Bioclinica (a subsidiary of Cinven, US)

, Certara L.P. (US)

, Celerion, Inc. (US)

, ERT, Inc. (US).

, Laboratory Corporation of America Holdings (US)

, Medpace Holdings, Inc. (US)

, Ncardia AG (Belgium)

, Richmond Pharmacology (UK)

, PhysioStim (France)

, Shanghai Medicilon Inc. (China)

, SGS S.A. (Switzerland)

, BioTelemetry, Inc. (US)

, IQVIA (US)

, Pharmaceutical Product Development LLC (US).

How the Cardiac Safety Services Market report helps you
In summary, our 140+ page report provides you with the following knowledge:
, Revenue forecasts to 2031 for each of the above mentioned segments each forecasted at a global and regional level, growth of all segments on regional level helps to understand most lucrative segment.

, Revenue forecasts to 2031 for 5 regional and 10 key national markets , the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.

, Prospects for established firms and those seeking to enter the market, including company profiles for over 10 of the major companies involved in the Cardiac Safety Services market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

COVID 19 Impact & Recovery Analysis on the Market
Currently, COVID-19 (Coronavirus) is prevalent across the globe. Many companies are underway to discover a vaccine, or therapeutics which can prevent or cure the COVID-19 virus. According to the World Health Organization, as of 13th September 2020, there were over 28,637,952 confirmed cases of COVID-19, with more than 917,417 deaths, globally.

The COVID-19 disease is continuously disrupting the growth of various markets. However, the immediate effect of the pandemic is different. Some industries will register a drop in demand, various other markets will remain unchanged and display a promising growth opportunities. The healthcare centers, such as hospitals and diagnostic labs, have been investing heavily in maintaining the supply of essential equipment and drugs. Due to lockdown across the globe, people were unable to reach healthcare facilities and non-urgent procedures were advised to put hold which impacted the healthcare industry a lot.

Due to COVID 19 pandemic patients were reluctant in visiting hospitals or clinics for their treatments and preferred virtual doctor visits. Lockdown across the globe due to the pandemic led to the delay of procedures which were not urgent. These factors negatively impacted the Cardiac Safety Services market for limited period of time. However, slowly the situation is getting back to normal everywhere and the market discussed is expected to increase in future.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Cardiac Safety Services market and leading companies. You will find data, trends and predictions.

The Cardiac Safety Services Market 2021-2031 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Cardiac Safety Services industry.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Cardiac Safety Services Market Analysis: Forecasts by Type (Standalone, Integrated), Services (ECG/Holter Measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed , order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated VISIONGAIN Reports
1.8. About VISIONGAIN
2. Introduction to theCardiac Safety Services Market
2.1. Cardiac Safety Services Market Definition
2.2. Type of Service Submarkets Definitions
2.3. End User Submarkets Definitions
2.4. Mode Submarkets Definitions
3. Cardiac Safety Services Market Overview
3.1. Global Cardiac Safety Services Market Size and Forecast by Region
3.2. Global Cardiac Safety Services Market Share by Region
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increased Subcontracting of R&D Events
3.3.1.2. Rising R&D Outlay in the Pharmaceutical & Biopharmaceutical Business
3.3.2. Opportunities
3.3.2.1. Overview of New Technologies and Methods
3.3.3. Challenges
3.3.3.1. Great Cost of Cardiac Care Assessment
4. Global Cardiac Safety Services Market Analysis and Forecast 2021-2031, by Type of Service (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. ECG Holter Measurement
4.2. Blood pressure measurement
4.3. Cardiovascular imaging
4.4. Thorough QT Studies
4.5. Other services
5. Cardiac Safety Services Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.2. Pharmaceuticals and Biopharmaceuticals Companies
5.3. Contract Research Organizations
6. North AmericaCardiac Safety Services Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North AmericaCardiac Safety Services Market Size and Forecast byType of Service
6.3. North AmericaCardiac Safety Services Market Size and Forecast byEnd User
6.4. U.S. Cardiac Safety Services Market
6.5. Canada Cardiac Safety Services Market
7. EuropeCardiac Safety Services Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Cardiac Safety Services Market Size and Forecast by Type of Service
7.3. Europe Cardiac Safety Services Market Size and Forecast by End User
7.4. UK Cardiac Safety Services Market
7.5. GermanyCardiac Safety Services Market
7.6. FranceCardiac Safety Services Market
7.7. Rest of EuropeCardiac Safety Services e Market
8. Asia PacificCardiac Safety Services Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia PacificCardiac Safety Services Market Size and Forecast by Type of Service
8.3. Asia PacificCardiac Safety Services Market Size and Forecast by End User
8.4. China Cardiac Safety Services Market
8.5. IndiaCardiac Safety Services Market
8.6. JapanCardiac Safety Services Market
8.7. Rest of Asia PacificCardiac Safety Services c Market
9. Latin AmericaCardiac Safety Services Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin AmericaCardiac Safety Services Market Size and Forecast by Type of Service
9.3. Latin AmericaCardiac Safety Services Market Size and Forecast by End User
9.4. BrazilCardiac Safety Services Market
9.5. Mexico Cardiac Safety Services Market
9.6. Rest of Latin America Cardiac Safety Services Market
10. MEA Cardiac Safety Services Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEACardiac Safety Services Market Size and Forecast by Type of Service
10.3. MEACardiac Safety Services Market Size and Forecast by End User
10.4. GCC Cardiac Safety Services Market
10.5. South AfricaCardiac Safety Services Market
10.6. Rest of MEA Cardiac Safety Services Market
11. Companies in theCardiac Safety Services Market
11.1. Bioclinica (A Subsidiary of Cinven)
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Product Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Labcorp.
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. Biotelemetry, Inc
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2019)
11.4. ERT, Inc.
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2019)
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue, 2019
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2019)
11.5. Banook Group
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2019)
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue, 2019
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2019)
11.6. IQVIA.
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2019)
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue, 2019
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2019)
11.7. Biotrial
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2019)
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue, 2019
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2019)
11.8. Medpace
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2019)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue, 2019
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2019)
11.9. Richmond Pharmacology
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2019)
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue, 2019
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2019)
11.10. PhysioStim
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2019)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue, 2019
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2019)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated VISIONGAIN Reports
VISIONGAIN Report Sales Order Form
Appendix A
About VISIONGAIN
Appendix B
VISIONGAIN report evaluation form

LIST OF TABLES
Table No 1: Cardiac Safety Services Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 2: Cardiac Safety Services Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 3: Cardiac Safety Services Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 4: Cardiac Safety Services Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 5: Cardiac Safety Services Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 6: Cardiac Safety Services Market Drivers & Restraints 2020
Table No 7: Cardiac Safety Services Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 8: Cardiac Safety Services Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 9: Cardiac Safety Services Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 10: Cardiac Safety Services Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 11: Cardiac Safety Services Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 12: ECG Holter Measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 13: ECG Holter Measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 14: ECG Holter Measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 15: ECG Holter Measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 16: ECG Holter Measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 17: Blood pressure measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 18: Blood pressure measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 19: Blood pressure measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 20: Blood pressure measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 21: Blood pressure measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 22: Cardiovascular imaging Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 23: Cardiovascular imaging Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 24: Cardiovascular imaging Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 25: Cardiovascular imaging Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 26: Cardiovascular imaging Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 27: Thorough QT Studies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 28: Thorough QT Studies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 29: Thorough QT Studies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 30: Thorough QT Studies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 31: Thorough QT Studies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 32: Other services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 33: Other services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 34: Other services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 35: Other services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 36: Other services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 37: Cardiac Safety Services Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 38: Cardiac Safety Services Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 39: Cardiac Safety Services Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 40: Cardiac Safety Services Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 41: Cardiac Safety Services Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 42: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 43: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 44: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 45: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 46: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 47: Contract Research Organizations Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 48: Contract Research Organizations Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 49: Contract Research Organizations Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 50: Contract Research Organizations Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 51: Contract Research Organizations Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 52: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 53: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 54: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 55: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 56: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 57: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 58: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 59: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 60: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 61: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 62: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 63: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 64: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 65: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 66: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 67: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 68: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 69: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 70: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 71: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 72: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 73: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 74: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 75: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 76: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 77: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 78: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 79: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 80: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 81: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 82: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 83: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 84: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 85: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 86: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 87: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 88: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 89: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 90: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 91: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 92: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 93: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 94: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 95: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 96: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 97: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 98: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 99: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 100: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 101: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 102: Asia Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 103: Asia Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 104: Asia Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 105: Asia Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 106: Asia Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 107: Asia Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 108: Asia Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 109: Asia Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 110: Asia Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 111: Asia Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 112: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 113: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 114: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 115: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 116: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 117: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 118: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 119: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 120: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 121: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 122: India Military Aircraft Fleet (Aircraft Type of Service, Number of Aircraft)
Table No 123: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 124: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 125: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 126: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 127: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 128: Japan Military Aircraft Fleet (Aircraft Type of Service, Number of Aircraft)
Table No 129: RoAPAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 130: RoAPAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 131: RoAPAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 132: RoAPAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 133: RoAPAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 134: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 135: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 136: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 137: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 138: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 139: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 140: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 141: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 142: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 143: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 144: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 145: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 146: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 147: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 148: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 149: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 150: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 151: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 152: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 153: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 154: Rest of Latin America Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 155: Rest of Latin America Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 156: Rest of Latin America Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 157: Rest of Latin America Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 158: Rest of Latin America Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 159: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 160: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 161: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 162: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 163: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 164: Middle East Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 165: Middle East Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 166: Middle East Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 167: Middle East Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 168: Middle East Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 169: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 170: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 171: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 172: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 173: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 174: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 175: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 176: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 177: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 178: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 179: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 180: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 181: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 182: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 183: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 184: Leading 10 Cardiac Safety Services Market Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table No 185: Bioclinica (A Subsidiary of Cinven). Profile (CEO, HQ, Founded, Website)
Table No 186: Bioclinica (A Subsidiary of Cinven). (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 187: Bioclinica (A Subsidiary of Cinven). (Net Income 2016-2019 (US$mn, AGR %)
Table No 188: Labcorp Profile (CEO, HQ, Founded, Website)
Table No 189: Labcorp (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 190: Labcorp (Net Income 2016-2019 (US$mn, AGR %)
Table No 191: Biotelemetry, Inc. Profile (CEO, HQ, Founded, Website)
Table No 192: Biotelemetry, Inc. (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 193: Biotelemetry, Inc. (Net Income 2016-2019 (US$mn, AGR %)
Table No 194: ERT, Inc. Profile (CEO, HQ, Founded, Website)
Table No 195: ERT, Inc. (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 196: ERT, Inc. (Net Income 2016-2019 (US$mn, AGR %))
Table No 197: Banook Group Profile (CEO, HQ, Founded, Website)
Table No 198: Banook Group Profile (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 199: Banook Group Profile (Net Income 2016-2019 (US$mn, AGR %))
Table No 200: IQVIA Profile (CEO, HQ, Founded, Website)
Table No 201: IQVIA (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 202: IQVIA (Net Income 2016-2019 (US$mn, AGR %))
Table No 203: Biotrial Profile (CEO, HQ, Founded, Website)
Table No 204: Biotrial (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 205: Biotrial (Net Income 2016-2019 (US$mn, AGR %))
Table No 206: Medpace. Profile (CEO, HQ, Founded, Website)
Table No 207: Medpace. (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 208: Medpace. (Net Income 2016-2019 (US$mn, AGR %))
Table No 209: Richmond Pharmacology. (CEO, HQ, Founded, Website)
Table No 210: Richmond Pharmacology. (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 211: Richmond Pharmacology. (Net Income 2016-2019 (US$mn, AGR %))
Table No 212: PhysioStim Profile (CEO, HQ, Founded, Website)
Table No 213: PhysioStim (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 214: PhysioStim (Net Income 2016-2019 (US$mn, AGR %))
Table No 215: Other Companies Cardiac Safety Services Market 2020 (Company, Location)

LIST OF FIGURES
Figure No 1: Cardiac Safety Services Market Type of Service Overview
Figure No 2: Cardiac Safety Services Market Technologyr Overview
Figure No 3: Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 4: Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 5: Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 6: Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 7: Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 8: Cardiac Safety Services Submarket Forecast by Type of Service 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure No 9: Cardiac Safety Services Submarket Forecast by Type of Service 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure No 10: Cardiac Safety Services Submarket Forecast by Type of Service 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 11: Cardiac Safety Services Submarket Forecast by Type of Service 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 12: Cardiac Safety Services Submarket Forecast by Type of Service 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 13: ECG Holter Measurement 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 14: ECG Holter Measurement 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 15: ECG Holter Measurement 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 16: ECG Holter Measurement 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 17: ECG Holter Measurement 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 18: Blood pressure measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 19: Blood pressure measurement Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 20: Blood pressure measurement Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 21: Blood pressure measurement Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 22: Blood pressure measurement Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 23: Cardiovascular imaging Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 24: Cardiovascular imaging Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 25: Cardiovascular imaging Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 26: Cardiovascular imaging Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 27: Cardiovascular imaging Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 28: Thorough QT Studies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 29: Thorough QT Studies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 30: Thorough QT Studies Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 31: Thorough QT Studies Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 32: Thorough QT Studies Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 33: Other services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 34: Other services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 35: Other services Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 36: Other services Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 37: Other services Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 38: Cardiac Safety Services Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure No 39: Cardiac Safety Services Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure No 40: Cardiac Safety Services Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 41: Cardiac Safety Services Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 42: Cardiac Safety Services Submarket Forecast by End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 43: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 44: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 45: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 46: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 47: Pharmaceuticals and Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 48: Contract Research Organizations Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 49: Contract Research Organizations Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 50: Contract Research Organizations Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure No 51: Contract Research Organizations Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure No 52: Contract Research Organizations Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure No 53: Regional Cardiac Safety Services Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure No 54: Regional Cardiac Safety Services Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure No 55: Regional Cardiac Safety Services Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure No 56: Regional Cardiac Safety Services Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure No 57: Regional Cardiac Safety Services Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure No 58: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 59: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 60: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 61: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 62: North America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 63: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %)
Figure No 64: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 65: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 66: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 67: North America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 68: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 69: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 70: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 71: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 72: US Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 73: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %)
Figure No 74: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 75: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 76: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 77: Canada Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 78: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (Before COVID)
Figure No 79: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario V)
Figure No 80: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario U)
Figure No 81: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario W)
Figure No 82: Europe Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario L)
Figure No 83: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %)
Figure No 84: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 85: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 86: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 87: Europe Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 88: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 89: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 90: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 91: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 92: UK Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 93: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %)
Figure No 94: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 95: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 96: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 97: Germany Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 98: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %)
Figure No 99: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 100: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 101: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 102: France Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 103: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 104: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 105: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 106: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 107: Rest of Europe Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 108: Asia-Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (Before COVID)
Figure No 109: Asia-Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario V)
Figure No 110: Asia-Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario U)
Figure No 111: Asia-Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario W)
Figure No 112: Asia-Pacific Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario L)
Figure No 113: Asia-Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %)
Figure No 114: Asia-Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 115: Asia-Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 116: Asia-Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 117: Asia-Pacific Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 118: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %)
Figure No 119: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 120: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 121: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 122: China Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 123: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %)
Figure No 124: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 125: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 126: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 127: India Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 128: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 129: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 130: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 131: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 132: Japan Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 133: Rest of APAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 134: Rest of APAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 135: Rest of APAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 136: Rest of APAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 137: Rest of APAC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 138: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M)
Figure No 139: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario V)
Figure No 140: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario U)
Figure No 141: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario W)
Figure No 142: Latin America Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario L)
Figure No 143: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M)
Figure No 144: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure No 145: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure No 146: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure No 147: Latin America Cardiac Safety Services Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure No 148: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 149: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 150: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 151: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 152: Brazil Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 153: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 154: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 155: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 156: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 157: Mexico Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 158: Rest of Latin America Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 159: Rest of Latin Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 160: Rest of Latin Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 161: Rest of Latin Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 162: Rest of Latin Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 163: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (Before COVID)
Figure No 164: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario V)
Figure No 165: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario U)
Figure No 166: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario W)
Figure No 167: Middle East Cardiac Safety Services Market Forecast by Type of Service 2021-2031 (US$M) (COVID - Scenario L)
Figure No 168: Middle East Cardiac Safety Services Market Forecast by End Use 2021-2031 (US$M) (Before COVID)
Figure No 169: Middle East Cardiac Safety Services Market Forecast by End Use 2021-2031 (US$M) (COVID - Scenario V)
Figure No 170: Middle East Cardiac Safety Services Market Forecast by End Use 2021-2031 (US$M) (COVID - Scenario U)
Figure No 171: Middle East Cardiac Safety Services Market Forecast by End Use 2021-2031 (US$M) (COVID - Scenario W)
Figure No 172: Middle East Cardiac Safety Services Market Forecast by Application 2021-2031 (US$M) (COVID - Scenario L)
Figure No 173: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 174: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 175: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 176: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 177: GCC Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 178: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 179: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 180: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 181: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 182: South Africa Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 183: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 184: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 185: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 186: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 187: Rest of MEA Cardiac Safety Services Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 188: Bioclinica (A Subsidiary of Cinven). (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 189: Bioclinica (A Subsidiary of Cinven). (Net Income 2016-2019 (US$mn, AGR %)
Figure No 190: Labcorp (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 191: Labcorp (Net Income 2016-2019 (US$mn, AGR %)
Figure No 192: Biotelemetry, Inc (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 193: Biotelemetry, Inc (Net Income 2016-2019 (US$mn, AGR %)
Figure No 194: ERT, Inc. (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 195: ERT, Inc. (Net Income 2016-2019 (US$mn, AGR %))
Figure No 196: Banook Group (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 197: Banook Group (Net Income 2016-2019 (US$mn, AGR %))
Figure No 198: IQVIA (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 199: IQVIA (Net Income 2016-2019 (US$mn, AGR %))
Figure No 200: Biotrial (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 201: Biotrial (Net Income 2016-2019 (US$mn, AGR %))
Figure No 202: Medpace. (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 203: Medpace. (Net Income 2016-2019 (US$mn, AGR %))
Figure No 204: Richmond Pharmacology.. (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 205: Richmond Pharmacology.. (Net Income 2016-2019 (US$mn, AGR %))
Figure No 206: PhysioStim (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 207: PhysioStim (Net Income 2016-2019 (US$mn, AGR %))

Companies Profiled in the Report
1. Biotrial (France)
2. Banook Group (France & Canada)
3. Bioclinica (a subsidiary of Cinven, US)
4. Certara L.P. (US)
5. Celerion, Inc. (US)
6. ERT, Inc. (US).
7. Laboratory Corporation of America Holdings (US)
8. Medpace Holdings, Inc. (US)

List of Companies Mentioned in the Report
1.Covance Inc.
2. Spaulding Clinical Research, LLC
3. Ncardia AG (Belgium)
4. Richmond Pharmacology (UK)
5. PhysioStim (France)
6. Shanghai Medicilon Inc. (China)
7. SGS S.A. (Switzerland)
8. BioTelemetry, Inc. (US)
9. IQVIA (US)
10. Pharmaceutical Product Development LLC (US).
11. Biotrial (France)
12. Banook Group (France & Canada)
13. Bioclinica (a subsidiary of Cinven, US)
14. Certara L.P. (US)
15. Celerion, Inc. (US)
16. ERT, Inc. (US)
17. Laboratory Corporation of America Holdings (US)
18. Medpace Holdings, Inc. (US)

List of Organizations Mentioned in the Report
1. Metrics Champion Consortium (MCC)
2. Cardiac Safety Research Consortium (CSRC)
3. International CardioOncology Society (ICOS)
4. ICH-E14 expert advisory panel
5. American Society of Hypertension (ASH)
6. American Telemedicine Association (ATA)